Restoration of BIM expression was shown to resensitize KRAS-mutant human and mouse cancer cells to combined PI3K and MEK inhibition, implying a role for targeting specific apoptotic mediators in addition to PI3K and MEK. The gene discussed is PIK3CA; the disease is cancer.